Skip to main content

Health condition · Clinically reviewed

Goitre, what an enlarged thyroid means - and how UK specialists sort it out.

A goitre can be diffuse or nodular, overactive, underactive or normal - and most are benign. The right blood tests, a specialist ultrasound and, when needed, an FNA quickly narrow down the cause.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against British Thyroid Association, NICE and peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK thyroid practice including TIRADS ultrasound, FNA, radioiodine and thyroidectomy pathways.

Key facts

Goitre at a glance.

The essentials, in plain English - the six types you might hear about, what the first assessment covers and how UK care is organised.

  • What it is

    Any enlargement of the thyroid gland - diffuse, nodular, retrosternal or malignant, and euthyroid, hyperthyroid or hypothyroid.

  • Diffuse causes

    Graves disease, Hashimoto thyroiditis, colloid change, iodine deficiency and subacute (de Quervain) thyroiditis.

  • Nodular causes

    Single thyroid nodule or multinodular goitre - some functioning autonomously and causing hyperthyroidism.

  • When to worry

    Compressive symptoms, hoarseness, rapid growth, fixed hard swelling or cervical lymphadenopathy warrant urgent review.

  • First assessment

    TFTs (TSH, free T4, free T3), thyroid antibodies and a thyroid ultrasound with TIRADS scoring.

  • Definitive care

    Antithyroid drugs, radioiodine, levothyroxine or thyroidectomy - matched to the type, function and size.

Why this guide matters

Six types, one clear pathway.

Goitres are usually described as diffuse, nodular, toxic, euthyroid, retrosternal or malignant. The three points below shape how the diagnosis, monitoring and treatment on this page fit together.

  • Function first

    A TSH-led blood panel classifies the goitre as hyperthyroid (for example Graves - see /conditions/graves-disease/), hypothyroid (Hashimoto - see /conditions/hypothyroidism/) or euthyroid.

  • Structure second

    A specialist thyroid ultrasound with TIRADS scoring characterises any nodules, and FNA follows for suspicious lesions per British Thyroid Association guidance.

  • MDT for the tricky ones

    Retrosternal, compressive, malignant and RET-mutant medullary thyroid cancer cases go to a specialist commissioned thyroid MDT with endocrinology, surgery, radiology and oncology.

How the diagnosis is made

From a lump you noticed to a clear plan.

The steps a UK GP, endocrinologist or thyroid surgeon will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    History and neck examination

    Duration, growth rate, compressive symptoms, family history and a structured palpation of the thyroid, trachea and cervical nodes.

  2. 02

    Assessing

    Thyroid function tests

    TSH first, then free T4 and free T3 - classifies the goitre as hyperthyroid, hypothyroid or euthyroid.

  3. 03

    Assessing

    Thyroid autoantibodies

    TPO and thyroglobulin antibodies for autoimmune disease; TRAb when Graves disease is suspected.

  4. 04

    Confirming

    Thyroid ultrasound with TIRADS

    A specialist thyroid ultrasound characterises nodules and applies TIRADS - the standard risk-stratification score in UK practice.

  5. 05

    Confirming

    Fine-needle aspiration (FNA)

    Guided FNA of suspicious nodules per British Thyroid Association guidelines, reported using the Thy1 to Thy5 system.

  6. 06

    Confirming

    CT for retrosternal extension

    CT of the neck and thorax when a goitre extends behind the sternum or causes tracheal deviation. Specialist commissioned imaging.

  7. 07

    Preparing

    Thyroid MDT review

    A specialist thyroid MDT (endocrinology, surgery, radiology, pathology, oncology) sets the plan for suspicious, compressive or malignant disease. Specialist commissioned pathway.

Typical timeline: first consultation to a definitive plan in a few weeks in specialist care.

Symptoms

What a goitre can look and feel like.

The visible neck swelling most people notice first, plus the compressive and hormonal features that decide urgency and treatment.

  • Visible neck swelling

    A smooth diffuse enlargement or a lumpy multinodular gland - often noticed by a partner or on a photograph.

  • Cosmetic concern

    Even a modest goitre can be highly visible and distressing - a legitimate reason to seek assessment.

  • Dysphagia

    Difficulty swallowing solids as the enlarged gland presses on the oesophagus behind the trachea.

  • Dyspnoea and stridor

    Breathlessness, night-time stridor or positional wheeze from tracheal compression - a red flag.

  • Hoarseness

    A change in voice can indicate recurrent laryngeal nerve involvement and needs urgent ENT review.

  • Hyperthyroid features

    Weight loss, tremor, palpitations, heat intolerance and anxiety - classic in Graves or a toxic nodule.

  • Hypothyroid features

    Fatigue, weight gain, cold intolerance, dry skin and low mood - typical of Hashimoto thyroiditis.

  • Pemberton sign and SVC obstruction

    Facial plethora, distended neck veins and dizziness on raising the arms - a retrosternal goitre compressing the superior vena cava.

Treatment

How goitre is treated in the UK.

Matched to the type and function - observation for small euthyroid glands, antithyroid drugs or radioiodine for overactive goitres, levothyroxine for underactive ones and thyroidectomy for compressive or malignant disease. See our thyroidectomy and thyroid clinic guides for detail.

  • Watchful observation

    Small, euthyroid, asymptomatic goitres with benign ultrasound features can be safely monitored with periodic TFTs and ultrasound.

  • Antithyroid drugs

    Carbimazole (first line) or propylthiouracil (PTU) suppress hormone production in Graves disease or a toxic goitre.

  • Radioiodine therapy

    Oral I-131 shrinks a toxic multinodular goitre or treats Graves - well established, outpatient based, contraindicated in pregnancy.

  • Levothyroxine replacement

    The standard therapy for hypothyroid goitre from Hashimoto thyroiditis - see our thyroid clinic guide for follow-up.

  • Thyroidectomy

    Total or hemi-thyroidectomy for compressive, retrosternal, cosmetically troublesome or malignant goitre. Specialist commissioned pathway.

  • Ethanol ablation for cysts

    Percutaneous ethanol injection can safely shrink recurrent benign thyroid cysts and avoid surgery in selected cases.

  • Radiofrequency ablation (RFA)

    A minimally invasive option to shrink benign symptomatic thyroid nodules - offered in selected specialist UK centres.

  • Systemic therapy for cancer

    Radioiodine after total thyroidectomy for differentiated thyroid cancer; tyrosine kinase inhibitors (lenvatinib, sorafenib, selpercatinib, pralsetinib) for advanced or RET-mutant disease.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP, endocrinologist or thyroid surgeon knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • British Thyroid Association. Guidelines for the management of thyroid cancer and thyroid nodules.

  • NICE. Thyroid disease: assessment and management (NG145).

  • Royal College of Physicians. UK guidelines for the use of thyroid function tests.

  • European Thyroid Association. Guidelines on ultrasound risk stratification and management of thyroid nodules.

Red flags

When a goitre needs urgent attention.

Most goitres are safely managed in the outpatient clinic. These are the situations that need faster action or specialist input.

  • Stridor or acute breathlessness

    Airway compromise from a large or retrosternal goitre is a medical emergency - call 999 or attend the nearest emergency department.

  • Rapidly growing neck mass

    A goitre that enlarges over weeks - especially if hard and fixed - can suggest anaplastic thyroid cancer or lymphoma. Urgent 2-week-wait referral.

  • New hoarseness

    Persistent voice change with a thyroid mass raises concern for recurrent laryngeal nerve involvement and warrants urgent ENT review.

  • Cervical lymphadenopathy

    Firm neck nodes alongside a thyroid nodule need urgent imaging and FNA for possible papillary thyroid cancer.

  • Pemberton sign

    Facial congestion and venous distension when the arms are raised - a classic sign of thoracic inlet obstruction from retrosternal goitre.

  • Thyroid storm

    Fever, tachycardia, agitation and confusion in severe hyperthyroidism - a life-threatening emergency needing hospital care.

  • Suspicious ultrasound features

    Microcalcifications, taller-than-wide shape, hypoechogenicity or irregular margins on ultrasound (TIRADS 4 or 5) require FNA.

  • Family history of thyroid cancer

    MEN2 and familial medullary thyroid cancer syndromes need genetic counselling and RET testing.

  • Neck pain with fever

    Painful subacute (de Quervain) thyroiditis or, rarely, acute suppurative thyroiditis needs prompt clinical review.

Living with it

A manageable condition, with a steady rhythm.

Four things that make the biggest difference day to day - keeping to your blood-test schedule, watching for compressive changes, sensible iodine intake and knowing where support lives.

A quiet reminder

Small habits, kept up for months.

Thyroid care is a long game - the annual review, the six-weekly TFT after a dose change, the note about new symptoms all matter more than a heroic month.

  1. 01 Monitoring

    Stick to your TFT schedule

    Whether you are on levothyroxine, carbimazole or watchful waiting, regular blood tests keep your dose - and your gland - on track.

  2. 02 Symptoms

    Log compressive changes

    Keep a note of any new breathlessness, night-time wheeze, swallowing difficulty or voice change and share it at your next appointment.

  3. 03 Lifestyle

    Iodine, gently

    A balanced UK diet gives enough iodine for most people. Avoid high-dose kelp or iodine supplements unless specifically advised.

  4. 04 Support

    You are not on your own

    The British Thyroid Foundation offers well-written patient resources and a helpline for questions between appointments.

Frequently asked

Everything we get asked about goitre.

Quick answers on causes, cancer risk, surgery, radioiodine, TIRADS and modern targeted drugs.

  • What is a goitre?

    A goitre is any enlargement of the thyroid gland. It can be diffuse (the whole gland is bigger) or nodular (with one or several lumps), and can be associated with an overactive, underactive or normally functioning thyroid.

  • Are all goitres cancerous?

    No. Most goitres in the UK are benign - due to Graves disease, Hashimoto thyroiditis, iodine variation, colloid change or benign nodules. A small proportion contain thyroid cancer, which is why ultrasound and, when indicated, FNA are important.

  • When does a goitre need surgery?

    Thyroidectomy is considered for compressive symptoms (dyspnoea, dysphagia, stridor), retrosternal extension, cosmetic concern that troubles the patient, hyperthyroidism not controlled by drugs or radioiodine, and any suspicion of malignancy. Surgery is delivered in specialist commissioned centres.

  • What is radioiodine treatment?

    Radioiodine (I-131) is a capsule or drink taken as an outpatient. It concentrates in overactive thyroid tissue and gradually shrinks the gland and settles hyperthyroidism. It is not used during pregnancy or breastfeeding and needs a short period of contact precautions.

  • What is TIRADS?

    TIRADS (Thyroid Imaging Reporting and Data System) is the ultrasound scoring system UK radiologists use to grade a nodule from 1 (benign) to 5 (highly suspicious). The score guides whether a fine-needle aspiration is needed. See our specialist radiology and thyroid clinic guides for detail.

  • What about the newer targeted drugs for thyroid cancer?

    Tyrosine kinase inhibitors such as lenvatinib and sorafenib are used in advanced radioiodine-refractory differentiated thyroid cancer. Selpercatinib and pralsetinib are RET-selective inhibitors used in RET-mutant medullary thyroid cancer identified through tumour molecular profiling.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.